# OnCo record nct06624644 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06624644/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06624644", "NCT06624644" ;
  schema:name "A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma"@en ;
  schema:description "A phase 2/3 trial testing LNS8801 in melanoma, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06624644/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06624644> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2025-08-06" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/advanced-melanoma/> ;
  onco:drugs <https://onco.cc/drugs/lns8801/> ;
  onco:companies <https://onco.cc/companies/linnaeus-therapeutics/> .